Activities of Rifamycin Derivatives Against Wild-Type and rpoB Mutants of Chlamydia Trachomatis
Antimicrobial Agents and Chemotherapy- United States
doi 10.1128/aac.49.9.3974-3976.2005
Full Text
Abstract
Available in
Date
September 1, 2005
Authors
Publisher
American Society for Microbiology